Need Help? Contact us via phone or e-mail. Your Feedback
login / join us
×
login
e-mail:
password:

News

UNODC releases the World Drug Report (WDR) 2017

Submitted by Heeyoung Park on 23rd June 2017

The 2017 World Drug Report(link is external) provides a global overview of the supply and demand of drugs and substances as well as their impact on health. In 2015 about a quarter of a billion people used drugs. Of these, around 29.5 million people - or 0.6 per cent of the global adult population - were engaged in problematic use and suffered from drug use disorders, including dependence. Opioids were the most harmful drug type and accounted for 70 per cent of the negative health impact associated with drug use disorders worldwide, according to the latest World Drug Report, released by UNODC. Disorders related to the use of amphetamines also account for a considerable share of the global burden of disease. And while the market for new psychoactive substances (NPS) is still relatively small, users are unaware of the content and dosage of psychoactive substances in some NPS. This potentially exposes users to additional serious health risks. This year marks 20 years of the World Drug Report, which comes at a time when the international community has decided to move forward with joint action. UNODC Executive Director Yury Fedotov highlighted that the outcome document of the 2016 landmark UN General Assembly special session on the world drug problem contains more than 100 concrete recommendations to reduce demand and supply, however he acknowledges that more needs to be done. "There is much work to be done to confront the many harms inflicted by drugs to health, development, peace and security, in all regions of the world," said Mr. Fedotov. The 2017 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health. It highlights the scientific evidence for hepatitis C causing greatest harm among people who use drugs; and brings into view further diversification of the thriving drug market, as well as changing business models for drug trafficking and organized crime.